Cyclosporiasis Risk: Who Faces the Highest Threat?

Cyclosporiasis, Cyclospora cayetanensis, Infectious Diseases, Gastrointestinal Infection, Foodborne Illness, Food Safety, Public Health, CDC, Diarrheal Disease, Immunocompromised Patients, HIV, Chemotherapy, Organ Transplant, Elderly Health, Pediatric Health, Infection Prevention, Healthcare Professionals, Nurses, Clinical Updates, Seasonal Infections, infectious diseases, immunocompromised patients, public health outbreak, parasite infection, infection prevention, diarrheal illness

Key Summary Cyclosporiasis cases are increasing across the U.S., with more than 1,645 confirmed cases in 34 states and thousands…

COVID-19

SARS-CoV-2, COVID-19, rhinovirus, common cold, pediatric COVID, HEROS study, interferon response, respiratory viruses, viral interference, immune priming, National Jewish Health, COVID protection, children immunity, respiratory infections, non-invasive research

Study Reveals Cold May Impact SARS-CoV-2 Infection Rates

The Unexpected Protective Role of Rhinoviruses in COVID-19 A groundbreaking study from National Jewish Health has revealed an intriguing phenomenon:…

Heart, Lung, & Brain Risks Persist in COVID-19 Survivors

A French nationwide study reveals that individuals hospitalized with COVID-19 remain at an increased risk of death and organ-related complications…

How COVID-19 and Vaccines Differ in Heart Inflammation

A team of international researchers led by the Max Delbrück Center for Molecular Medicine in Berlin has identified distinct immune…

Health and Wellness

FemTech, Women's Health, Healthcare Innovation, Digital Health, Telehealth, Reproductive Health, Health Equity, Personalized Medicine, Women's Healthcare Technology, Cardiovascular Disease, Cancer Care, Chronic Disease Management, Digital Therapeutics, Healthcare Access, Women's Health Research, Cardiovascular Disease in Women, Women's Cancer Care, Chronic Disease Management, Healthcare Disparities, Digital Therapeutics, Women's Health Innovation

Women’s Healthcare Advances Through FemTech

Key Summary FemTech has grown from menstrual tracking and fertility apps into a major women's healthcare technology sector. The industry…

Mazdutide Shows Significant Weight Loss in Phase 3 Trial

Key Summary Mazdutide, a dual GLP-1 and glucagon receptor agonist, achieved 16.65% mean weight loss in adults with obesity. 84.3%…

Ozone Pollution Reduces Exercise Benefits in Children

Key Summary Vigorous physical activity supports lung growth in children aged 6 to 9. Long-term ozone pollution exposure reduces these…